Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemoblast Bellows for Sternal Hemostasis in Cardiac Surgery
NCT06511778Phase 4Recruiting
- Sponsor
- WakeMed Health
- Start
- Oct 2024
- Primary completion
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of thrombin + collagen (2 arms), sponsored by WakeMed Health. Primary endpoints: Sternal Bleeding Score (SPOT GRADE), Reoperation for Bleeding and 1 more. Started Oct 2024; status: recruiting.
02
Drugs
thrombin + collagen
Beyond the preview
Go deeper on NCT06511778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06511778.